Rifabutin Chemical Structure (Talicia 01)
Talicia Capsule, Delayed Release
Product Images NDC 57841-1150
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Talicia (NDC 57841-1150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redhill Biopharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Amoxicillin Chemical Structure (Talicia 02)
Omeprazole Magnesium Chemical Structure (Talicia 03)
Talicia Carton Label (Talicia 04)
Talicia is a prescription medication that comes in delayed-release capsules containing a combination of omeprazole magnesium, amoxicillin, and rifabutin. It is intended for use only with a prescription. Two bottles are provided, each containing 84 capsules. The product code is NDG 57881-11502 or NDG S7841-1150-2.*
Talicia Bottle Label (Talicia 05)
Talicia® is a delayed-release capsule medication manufactured in Sweden by RedHill Biopharma Inc. It contains a combination of omeprazole magnesium, amoxicillin, and rifabutin, and is prescribed for medical use only. The medication is available in 84 capsules, and each capsule must be stored in the original container with a child-resistant closure. It contains various inactive ingredients and must be stored between 20°C to 25°C (68°F to 77°F). The package insert provides more information regarding the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
